Exhibit B

Schedule of Transactions in Shares

Date of Transaction	Title of Class	Number of Shares Acquired	Number of Shares Disposed	Price Per Share

12/11/2025	Common Stock, par value $0.001		13,500 (1)	$31.2798 (2)
12/12/2025	Common Stock, par value $0.001		6,500 (1)	$31.0444 (3)

(1) The reported securities are owned directly by JEB Partners, L.P. (“JEB Partners”) and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC (“Manchester Management”), the general partner of Manchester Explorer, L.P. (“Explorer”), (ii) Manchester Management PR, LLC (“Manchester PR”), the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

(2) The price reported is a weighted average price. These shares were sold in multiple transactions within the range of $31.05 to $31.525. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

(3) The price reported is a weighted average price. These shares were sold in multiple transactions within the range of $30.765 to $31.60. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The Form 4 filed by Reporting Persons on December 15, 2025 is incorporated herein by reference.

SANUWAVE Health, Inc. SCHEDULE 13D/A